Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRANSLINK: A Prospective, Multi-center, Multi-national, Non Randomized, Open, Study to Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves.

NCT02023970 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02023970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRANSLINK: A Prospective, Multi-center, Multi-national, Non Randomized, Open, Study to Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves.
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2014
Completion date
January 10, 2018
Enrollment
1,668 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

patients receiving animal-derived bioprosthetic heart valves